{"id":"W2954147811","doi":"10.1016/j.euo.2019.06.002","title":"Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Roche; Merck","keywords":"Cystectomy; Medicine; Bladder cancer; Chemotherapy; Cisplatin; Oncology; Guideline; Cancer; Neoadjuvant therapy; Internal medicine; Clinical trial; DNA Damage Repair; DNA repair; Pathology; Gene; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000326936,0.0001961225,0.0004800292,0.0001370856,0.00003211978,0.000004871967,0.0001996012,0.0001147624,0.0009980258],"category_scores_gemma":[0.00004959465,0.0001325213,0.0001031381,0.0002107234,0.0002948534,0.00003504424,0.00006957757,0.0002783031,0.0001311573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001629116,"about_ca_system_score_gemma":0.0003768397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001478334,"about_ca_topic_score_gemma":0.0007609788,"domain_scores_codex":[0.9981675,0.0005406461,0.0004283626,0.0003632103,0.0001239811,0.0003763073],"domain_scores_gemma":[0.9989666,0.0002183911,0.0001687053,0.0004933711,0.00006766849,0.00008527491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005964007,0.001262654,0.6843957,0.0000597587,0.001829568,0.001127311,0.004155837,0.0003822306,0.0250195,0.000326951,0.06220192,0.2132746],"study_design_scores_gemma":[0.007471111,0.002410823,0.3996229,0.00001732191,0.0001489615,0.00015404,0.0000898091,0.0001291404,0.0005752281,0.00002696127,0.589224,0.0001296572],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.927575,0.0008997145,0.00001483919,0.02838987,0.0007255789,0.000892789,0.00003073696,0.00004492886,0.04142657],"genre_scores_gemma":[0.9751638,0.0006134705,0.0002633873,0.01989239,0.0001532188,0.00002676689,0.0000153713,0.00006010829,0.00381145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5270221,"threshold_uncertainty_score":0.9999152,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03674697873142426,"score_gpt":0.3119977905155355,"score_spread":0.2752508117841113,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}